TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33548748

Group type: EXPERIMENTAL
Intervention: Topical formulation of Plantago major standardized by HPLC (1.88 mg/100g of quercetin)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study: 32989062

Group type: COMPARATOR
Intervention: Standard practice support (practice facilitation, practice assessment with feedback, health information technology assistance, and collaborative learning sessions)
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Standard support plus patient engagement support
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Both arms of the intervention
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Enhanced intervention practices
Number of subjects: 211
Study: 35198412

Group type: EXPERIMENTAL
Intervention: ECA suggests a relevant topic to discuss
Number of subjects: 82

Group type: COMPARATOR
Intervention: User selects a topic from a set of options
Number of subjects: 82
Study: 32471400

Group type: EXPERIMENTAL
Intervention: A Healthy Generation programme (physical activity and healthy meals/fruit twice a week from August to May)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 157
Study: 34702564

Group type: EXPERIMENTAL
Intervention: Leaflet preservation strategy
Number of subjects: 104

Group type: COMPARATOR
Intervention: Leaflet resection strategy
Number of subjects: 104
Study: 33822086

Group type: EXPERIMENTAL
Intervention: PPAEAT (Perceptions of Preventable Adverse Events Assessment Tool)
Number of subjects: 210
Study: 32331079

Group type: EXPERIMENTAL
Intervention: Dasotraline (4-8 mg/d)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Dasotraline
Number of subjects: 317

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study: 34859618

Group type: EXPERIMENTAL
Intervention: Web-based nomogram for predicting distant metastasis (DM) risk in LMS patients
Number of subjects: 2184

Group type: EXPERIMENTAL
Intervention: Web-based nomogram
Number of subjects: 2184

Group type: EXPERIMENTAL
Intervention: Epithelioid LMS, older age, giant tumor, multiple organ metastasis, without surgery, and chemotherapy
Number of subjects: 2184
Study: 32961617

Group type: EXPERIMENTAL
Intervention: Irbesartan 300 mg
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 36050560

Group type: EXPERIMENTAL
Intervention: D‐PLEX100 plus standard of care (SOC)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 202
Study: 33648464

Group type: EXPERIMENTAL
Intervention: MiSight contact lenses (CL)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Single-vision spectacles (control)
Number of subjects: 74
Study: 32638017

Group type: EXPERIMENTAL
Intervention: Omentum preservation
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Omentectomy
Number of subjects: 1050
Study: 35304391

Group type: EXPERIMENTAL
Intervention: Monthly online ePROM symptom reporting
Number of subjects: 52

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 52
Study: 32583541

Group type: EXPERIMENTAL
Intervention: Blackberry-dill extract combination
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blackberry extract
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dill extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34230015

Group type: EXPERIMENTAL
Intervention: CONTRACT intervention involving family-oriented and supervised home-based training, diet, and electrical muscle stimulation for 6 months.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care as offered by local hospital or community (Control group).
Number of subjects: 50
Study: 35720173

Group type: EXPERIMENTAL
Intervention: Maternal nutrition education (breast-feeding education)
Number of subjects: 310
Study: 34814908

Group type: EXPERIMENTAL
Intervention: High-quality nursing based on childlike interest
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 62
Study: 35882814

Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g per packet, 1 packet per day for 2 weeks)
Number of subjects: 17
Study: 34333414

Group type: EXPERIMENTAL
Intervention: BoPo posts featuring average-size women
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: BoPo posts featuring larger women
Number of subjects: 167

Group type: COMPARATOR
Intervention: BoPo posts (both conditions)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Travel/Control
Number of subjects: 167
Study: 32107360

Group type: EXPERIMENTAL
Intervention: BCTC
Number of subjects: 32

Group type: COMPARATOR
Intervention: A‐967079
Number of subjects: 32

Group type: COMPARATOR
Intervention: Amiloride
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combination of all 3 antagonists (BCTC, A‐967079, amiloride)
Number of subjects: 32
Study: 35611069

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg twice daily
Number of subjects: 1372

Group type: EXPERIMENTAL
Intervention: Bupropion 150 mg twice daily
Number of subjects: 1372

Group type: EXPERIMENTAL
Intervention: Nicotine patches 21 mg/day with taper
Number of subjects: 1372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1372
Study: 34056910

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of HF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Age ≥66 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weight
Number of subjects: 0
Study: 32281732

Group type: EXPERIMENTAL
Intervention: Diet soda containing sucralose and acesulfame‐potassium (Ace‐K) consumed three times daily for 8 weeks
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Diet soda containing sucralose and acesulfame‐potassium (Ace‐K)
Number of subjects: 7
Study: 35045221

Group type: EXPERIMENTAL
Intervention: Lenvatinib (20 mg orally once daily) plus Pembrolizumab (200 mg intravenously every 3 weeks)
Number of subjects: 827

Group type: COMPARATOR
Intervention: Chemotherapy (doxorubicin at 60 mg/m² every 3 weeks or paclitaxel at 80 mg/m² weekly)
Number of subjects: 827

Group type: EXPERIMENTAL
Intervention: Lenvatinib plus Pembrolizumab
Number of subjects: 827

Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 827
Study: 34108078

Group type: EXPERIMENTAL
Intervention: Sufentanil 1.91 μg (ED90)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sufentanil 2 μg (recommended dosage)
Number of subjects: 40
Study: 33032824

Group type: EXPERIMENTAL
Intervention: Loop Electrosurgical Excision Procedure (LEEP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cold Knife Cone Biopsy (CKC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: CKC
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: LEEP
Number of subjects: 40
Study: 34516998

Group type: COMPARATOR
Intervention: Education (E)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Transportation Incentives (T)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Transportation & Sessions Incentives (T&S)
Number of subjects: 266
Study: 33303468

Group type: EXPERIMENTAL
Intervention: Dose-escalated (69 Gy) functional avoidance radiation therapy
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Functional avoidance radiation therapy
Number of subjects: 20
Study: 35696071

Group type: EXPERIMENTAL
Intervention: Venetoclax + Azacitidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Azacitidine
Number of subjects: 0
Study: 32514830

Group type: EXPERIMENTAL
Intervention: Robotic instrument group (Group Rob)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional instrument group (Group Conv)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group Rob
Number of subjects: 40
Study: 33233510

Group type: EXPERIMENTAL
Intervention: Rosemary extract
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21
Study: 36055304

Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg intravenously every 3 weeks for up to 17 cycles
Number of subjects: 994

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 994

Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 994
Study: 33270187

Group type: EXPERIMENTAL
Intervention: Equation based on serum β2-microglobulin (β2M), creatinine, urea, age, and gender
Number of subjects: 511

Group type: COMPARATOR
Intervention: Standard of care (24-h urine collection)
Number of subjects: 511
Study: 35346330

Group type: EXPERIMENTAL
Intervention: Consumption of products with low amounts of PN or TN on a regular basis, starting with 1/100 of their individual threshold, increasing to 1/50 and 1/10 after 4 and 8 months, respectively.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Strict avoidance of PN or TN for 1 year.
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Regular consumption of PN and/or TN for sensitized but tolerant subjects.
Number of subjects: 120
Study: 32892317

Group type: EXPERIMENTAL
Intervention: Tailored written advice targeting lifestyle according to current guidelines
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 111
Study: 32302788

Group type: EXPERIMENTAL
Intervention: Computerized clinical decision support (CDS) tool for AF management
Number of subjects: 1145

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1145
Study: 33576204

Group type: EXPERIMENTAL
Intervention: 25mg subcutaneous progesterone (Prolutex, IBSA Switzerland)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 400mg vaginal progesterone (Cyclogest, Actoverco, United Kingdom)
Number of subjects: 0
Study: 32439205

Group type: EXPERIMENTAL
Intervention: Pseudomonas aeruginosa spray
Number of subjects: 200
Study: 35440940

Group type: EXPERIMENTAL
Intervention: HFNC combined with NIV (Humidified High Flow Nasal Cannula + Noninvasive Mechanical Ventilation)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine oxygen therapy combined with NIV (low flow conventional oxygen therapy + NIV)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HFNC combined with NIV
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine oxygen therapy combined with NIV
Number of subjects: 100
Study: 33509257

Group type: EXPERIMENTAL
Intervention: Modified MSFE
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard MSFE
Number of subjects: 25
Study: 32943231

Group type: EXPERIMENTAL
Intervention: 50% (v/v) DMSO wet‐bonding (DWB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.01%, 0.1%, and 1 wt% EGCG‐incorporated 50% (v/v) DMSO wet‐bonding (0.01%, 0.1%, and 1%EGCG/DWB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1%EGCG/DWB
Number of subjects: 0

Group type: COMPARATOR
Intervention: water wet‐bonding (WWB)
Number of subjects: 0
Study: 36042448

Group type: EXPERIMENTAL
Intervention: Concentrated Growth Factor (CGF)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (no CGF)
Number of subjects: 37
Study: 33983207

Group type: EXPERIMENTAL
Intervention: Random depolarization film (RDF) on display
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complex polarization-control technologies
Number of subjects: 0
Study: 36194310

Group type: EXPERIMENTAL
Intervention: Laparoscopic pelvic exenteration (LPE)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Open pelvic exenteration (OPE)
Number of subjects: 144
Study: 33472779

Group type: EXPERIMENTAL
Intervention: Individuals with knowledge of hypertension consequences and treatment options
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: Individuals who believed BP medications should be stopped from time to time
Number of subjects: 833

Group type: COMPARATOR
Intervention: Individuals who reported not taking daily treatment
Number of subjects: 833

Group type: EXPERIMENTAL
Intervention: Individuals listing BP medications as the most effective way to reduce BP
Number of subjects: 833
Study: 32500209

Group type: EXPERIMENTAL
Intervention: MDMA-assisted psychotherapy (75-125 mg doses during sessions)
Number of subjects: 0
Study: 32833889

Group type: EXPERIMENTAL
Intervention: Unilateral chest press (CP) training
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Handgrip training
Number of subjects: 30
Study: 32968946

Group type: EXPERIMENTAL
Intervention: S‐PRG filler‐containing coat
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: nonS‐PRG filler‐containing coat
Number of subjects: 3

Group type: COMPARATOR
Intervention: no coating (control)
Number of subjects: 3
Study: 32280083

Group type: EXPERIMENTAL
Intervention: Oral omega-3 poly-unsaturated fatty acids (n-3 PUFAs)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low calorie diet (LCD)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both groups (omega-3 and LCD)
Number of subjects: 56
Study: 36095308

Group type: EXPERIMENTAL
Intervention: Progesterone (up to 400 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 25
Study: 32940857

Group type: EXPERIMENTAL
Intervention: STRONG intervention
Number of subjects: 119

Group type: COMPARATOR
Intervention: Waitlist comparison group
Number of subjects: 119
Study: 32232721

Group type: EXPERIMENTAL
Intervention: Omaha system-based continuing nursing program
Number of subjects: 203

Group type: COMPARATOR
Intervention: Common outpatient nursing intervention
Number of subjects: 203
Study: 35845459

Group type: EXPERIMENTAL
Intervention: Tuina therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine rehabilitation control
Number of subjects: 84
Study: 33206043

Group type: EXPERIMENTAL
Intervention: Sleep hygiene instructions, including instructions to limit liquids at nighttime and empty bladder prior to bedtime
Number of subjects: 0

Group type: COMPARATOR
Intervention: No sleep instructions (Control)
Number of subjects: 0
Study: 33239038

Group type: EXPERIMENTAL
Intervention: Motivational interviewing
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Face-to-face information, motivation, and behavioral skills model
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Information, motivation, and behavioral skills model provided using a mobile application
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 120
Study: 35353333

Group type: EXPERIMENTAL
Intervention: 4 week course of doxycycline, streptomycin, and hydroxychloroquine (DSH)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: 6 week course of doxycycline, streptomycin, and hydroxychloroquine (DSH)
Number of subjects: 92
Study: 33677766

Group type: EXPERIMENTAL
Intervention: Connect through PLAY intervention
Number of subjects: 167

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 167
Study: 32497146

Group type: EXPERIMENTAL
Intervention: High-oleic and low-linolenic mutant breeding lines
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-yielding domestic canola-type breeding lines
Number of subjects: 0
Study: 33736862

Group type: EXPERIMENTAL
Intervention: Kois Dento‐Facial Analyzer (KDFA)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Panadent Pana‐Mount Facebow (PMF)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Kinematic Axis (KA)
Number of subjects: 15
Study: 34270348

Group type: EXPERIMENTAL
Intervention: MIBG (18 mCi/kg on day 1)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: MIBG + Vincristine (IV on day 0) + Irinotecan (daily on days 0-4)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: MIBG + Vorinostat (180 mg/m2/dose orally once daily on days 1 to 12)
Number of subjects: 105

Group type: COMPARATOR
Intervention: MIBG
Number of subjects: 105

Group type: COMPARATOR
Intervention: MIBG + Vincristine + Irinotecan
Number of subjects: 105

Group type: COMPARATOR
Intervention: MIBG + Vorinostat
Number of subjects: 105
Study: 32690001

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT) - single dose (wavelength 830nm, energy 2J/point) applied at four points (2 buccal, 2 palatal) for each maxillary anterior tooth root.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo treatment - same application procedure without emitting the laser beam.
Number of subjects: 26
Study: 35422183

Group type: EXPERIMENTAL
Intervention: Glyphosate low dose of 7.2 g a.e. ha‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyphosate low dose of 36.0 g a.e. ha‐1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glyphosate low dose of 108.0 g a.e. ha‐1
Number of subjects: 0
Study: 33676014

Group type: EXPERIMENTAL
Intervention: Cycling for 30 minutes
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Running for 30 minutes
Number of subjects: 20

Group type: COMPARATOR
Intervention: Resting
Number of subjects: 20
Study: 34592023

Group type: EXPERIMENTAL
Intervention: BES-SMFR
Number of subjects: 68

Group type: COMPARATOR
Intervention: BES
Number of subjects: 68
Study: 33812261

Group type: EXPERIMENTAL
Intervention: Ozone therapy (ozonated water at 25 µg/mL concentration and ozone gas)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (saline irrigation)
Number of subjects: 60
Study: 33167759

Group type: EXPERIMENTAL
Intervention: Intular Scope™ (IS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Direct Laryngoscope (DL)
Number of subjects: 70
Study: 36414261

Group type: EXPERIMENTAL
Intervention: Argon laser photocoagulation (one session applied to anterior chamber nodules)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Topical steroid and cycloplegic eye drops with trans-septal triamcinolone injections
Number of subjects: 48
Study: 33113053

Group type: EXPERIMENTAL
Intervention: Full-field organ dose modulation (ODM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Regular scanning patterns
Number of subjects: 80
Study: 32727938

Group type: EXPERIMENTAL
Intervention: Test TCV
Number of subjects: 240

Group type: COMPARATOR
Intervention: Comparator TCV
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Test TCV and Comparator TCV
Number of subjects: 240
Study: 34435252

Group type: EXPERIMENTAL
Intervention: GT (Rebilda bundled glass fiber-reinforced composite posts)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: RP (Rebilda conventional glass fiber posts)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: GT + RP (combined intervention)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control groups (nWnR, WnR, nWGT, WGT, nWRP, WRP)
Number of subjects: 80
Study: 34231948

Group type: EXPERIMENTAL
Intervention: WeChat platform management
Number of subjects: 566

Group type: COMPARATOR
Intervention: Traditional management method (Control)
Number of subjects: 566
Study: 32171945

Group type: EXPERIMENTAL
Intervention: Hypofractionated WBI
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional WBI
Number of subjects: 140
Study: 36420633

Group type: EXPERIMENTAL
Intervention: Solriamfetol 300 mg/day
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 32970198

Group type: EXPERIMENTAL
Intervention: T2D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FG
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HCadjBMI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WCadjBMI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDL cholesterol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heel BMD
Number of subjects: 0
Study: 36283750

Group type: EXPERIMENTAL
Intervention: Autologous cultured adipose derived mesenchymal stem cells (ADMSCs) combined with hyaluronic acid (HA) hydrogel
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 34386961

Group type: EXPERIMENTAL
Intervention: CycH8a ligand selected from a randomized 6-mer library; cyclization achieved through a cysteine–AcrK linker
Number of subjects: 0
Study: 33973407

Group type: EXPERIMENTAL
Intervention: Nurse-led consultation
Number of subjects: 280

Group type: COMPARATOR
Intervention: Rheumatologist follow-up
Number of subjects: 280
Study: 32868028

Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) exercise (twice/week for 24 weeks)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (calcium and vitamin D supplementation only)
Number of subjects: 43
Study: 34510197

Group type: EXPERIMENTAL
Intervention: Teen-Strong programme and standard sexual education
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard sexual education
Number of subjects: 66
Study: 34021094

Group type: EXPERIMENTAL
Intervention: 10INT
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CON
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 10CON
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 25CON
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 25INT
Number of subjects: 11
Study: 34337677

Group type: EXPERIMENTAL
Intervention: Miniscrews placed at 90° insertion angle
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Miniscrews placed at 45° insertion angle
Number of subjects: 25

Group type: COMPARATOR
Intervention: Miniscrews at 90°
Number of subjects: 25

Group type: COMPARATOR
Intervention: Miniscrews at 45°
Number of subjects: 25
Study: 32250572

Group type: COMPARATOR
Intervention: Tongue brushing (Intervention I)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Oral care tablet containing kiwifruit powder (Intervention II)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Three oral care tablets (Intervention III)
Number of subjects: 32
Study: 34705573

Group type: EXPERIMENTAL
Intervention: Post-mastectomy radiotherapy (PMRT)
Number of subjects: 1011
Study: 33309489

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Resistance training (RT)
Number of subjects: 128
Study: 34511090

Group type: EXPERIMENTAL
Intervention: MoM‐LDH‐THA
Number of subjects: 75

Group type: COMPARATOR
Intervention: MoM‐HR
Number of subjects: 75
Study: 32585854

Group type: EXPERIMENTAL
Intervention: Almega®PL (1 g/day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 36071165

Group type: EXPERIMENTAL
Intervention: Targeted therapy matched to genomic alteration
Number of subjects: 1462

Group type: EXPERIMENTAL
Intervention: Olaparib for patients with germline BRCA1/2 mutations
Number of subjects: 1462
Study: 34486130

Group type: EXPERIMENTAL
Intervention: varenicline
Number of subjects: 200

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 200
Study: 32845589

Group type: EXPERIMENTAL
Intervention: Halobetasol Propionate (HP) 0.01% lotion
Number of subjects: 430

Group type: COMPARATOR
Intervention: Vehicle lotion
Number of subjects: 430